Lipidio

Patients are at the center of all we do

San Diego, United States · Founded 2020

Employees
1–10
Founded
2020
Business Model
B2B
Last Round
Extension RoundNov 2022
Rounds
1

About

Lipidio Pharmaceuticals is a San Diego-based biopharmaceutical company founded in 2020 that acquires and develops molecules with unrealized therapeutic potential, applying its team's drug development expertise to optimize preclinical and clinical plans through to marketing approval or exit. The company is focused on two distinct indications: obesity and sebaceous hyperplasia, with a lead candidate that uses skin signaling mechanisms to deliver systemic metabolic benefits including significant weight reduction. Lipidio has raised over $20 million in Series A financing and has received support from the Foundation for Prader-Willi Research for its GDD3898 therapeutic candidate.

Summary

Lipidio is a Biotech company based in San Diego, United States, founded in 2020. Its most recent funding was an Extension Round in Nov 2022. Investors include Alethea Capital Management and 3E Bioventures Capital.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Extension RoundExtension RoundNov 2022

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Lipidio on Indexed.vc
<a href="https://indexed.vc/companies/lipidio"><img src="https://indexed.vc/api/badge/company/lipidio" alt="Lipidio on Indexed.vc" width="260" height="76" /></a>